• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于更新的 RUCAM 的儿童特发性药物性肝损伤患者的代谢组学分析

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.

机构信息

Bioinformatic Unit, Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain.

Department of Pediatrics, University of Granada, 18016 Granada, Spain.

出版信息

Int J Mol Sci. 2023 Sep 1;24(17):13562. doi: 10.3390/ijms241713562.

DOI:10.3390/ijms241713562
PMID:37686369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10487599/
Abstract

Hepatotoxicity, a common adverse drug effect, has been extensively studied in adult patients. However, it is equally important to investigate this condition in pediatric patients to develop personalized treatment strategies for children. This study aimed to identify plasma biomarkers that characterize hepatotoxicity in pediatric patients through an observational case-control study. Metabolomic analysis was conducted on 55 pediatric patients with xenobiotic liver toxicity and 88 healthy controls. The results revealed clear differences between the two groups. Several metabolites, including hydroxydecanoylcarnitine, octanoylcarnitine, lysophosphatidylcholine, glycocholic acid, and taurocholic acid, were identified as potential biomarkers (area under the curve: 0.817; 95% confidence interval: 0.696-0.913). Pathway analysis indicated involvement of primary bile acid biosynthesis and the metabolism of taurine and hypotaurine ( < 0.05). The findings from untargeted metabolomic analysis demonstrated an increase in bile acids in children with hepatotoxicity. The accumulation of cytotoxic bile acids should be further investigated to elucidate the role of these metabolites in drug-induced liver injury.

摘要

肝毒性是一种常见的药物不良反应,已在成年患者中进行了广泛研究。然而,同样重要的是要在儿科患者中研究这种情况,以便为儿童制定个性化的治疗策略。本研究旨在通过观察性病例对照研究,确定能够表征儿科患者肝毒性的血浆生物标志物。对 55 名具有外源性肝毒性的儿科患者和 88 名健康对照者进行了代谢组学分析。结果显示两组之间存在明显差异。几种代谢物,包括羟基癸酰肉碱、辛酰肉碱、溶血磷脂酰胆碱、甘胆酸和牛磺胆酸,被鉴定为潜在的生物标志物(曲线下面积:0.817;95%置信区间:0.696-0.913)。途径分析表明原发性胆汁酸生物合成和牛磺酸及次牛磺酸代谢参与其中(<0.05)。非靶向代谢组学分析的结果表明,肝毒性儿童的胆汁酸水平升高。应进一步研究细胞毒性胆汁酸的积累,以阐明这些代谢物在药物性肝损伤中的作用。

相似文献

1
Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM.基于更新的 RUCAM 的儿童特发性药物性肝损伤患者的代谢组学分析
Int J Mol Sci. 2023 Sep 1;24(17):13562. doi: 10.3390/ijms241713562.
2
Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.尿液代谢组学和微生物组学分析揭示了抗结核药物性肝损伤的作用机制,采用更新的 RUCAM 评估因果关系:一项前瞻性研究。
Front Immunol. 2022 Nov 22;13:1002126. doi: 10.3389/fimmu.2022.1002126. eCollection 2022.
3
Hepatotoxicity of cantharidin is associated with the altered bile acid metabolism.斑蝥素的肝毒性与胆汁酸代谢改变有关。
J Appl Toxicol. 2022 Jun;42(6):970-980. doi: 10.1002/jat.4267. Epub 2021 Dec 5.
4
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.通过代谢组学分析探索药物性肝损伤(DILI)反应中的个体差异。
Int J Mol Sci. 2024 Mar 5;25(5):3003. doi: 10.3390/ijms25053003.
5
Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.胆汁酸稳态的扰乱是大鼠药物性肝损伤的早期发病机制事件。
Toxicol Appl Pharmacol. 2013 Apr 1;268(1):79-89. doi: 10.1016/j.taap.2013.01.018. Epub 2013 Jan 27.
6
A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury.牛磺胆酸血清水平与药物性肝损伤的严重程度和恢复相关。
Clin Gastroenterol Hepatol. 2021 May;19(5):1009-1019.e11. doi: 10.1016/j.cgh.2020.06.067. Epub 2020 Jul 4.
7
Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.代谢组学和细胞因子分析用于鉴定严重药物性肝损伤。
J Proteome Res. 2019 Jun 7;18(6):2514-2524. doi: 10.1021/acs.jproteome.9b00047. Epub 2019 Apr 30.
8
Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury.人类血浆的纵向代谢组学揭示了抗结核药物性肝损伤的代谢动态和预测标志物。
Respir Res. 2024 Jun 21;25(1):254. doi: 10.1186/s12931-024-02837-8.
9
Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury.特异质性药物性肝损伤患者胆汁酸的靶向代谢组学分析
Metabolites. 2021 Dec 8;11(12):852. doi: 10.3390/metabo11120852.
10
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes.代谢组学分析用于鉴别药物性肝损伤(DILI)表型。
Arch Toxicol. 2021 Sep;95(9):3049-3062. doi: 10.1007/s00204-021-03114-z. Epub 2021 Jul 17.

引用本文的文献

1
Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques.药物性肝损伤研究进展:体外模型、机制、组学及基因调控技术
Cell Biosci. 2024 Nov 2;14(1):134. doi: 10.1186/s13578-024-01317-2.

本文引用的文献

1
The value of bile acid spectrum in the evaluation of hepatic injury in children with infectious mononucleosis caused by Epstein Barr virus infection.胆汁酸谱在评估由爱泼斯坦-巴尔病毒感染引起的传染性单核细胞增多症患儿肝损伤中的价值。
Front Pediatr. 2023 Mar 21;11:1109762. doi: 10.3389/fped.2023.1109762. eCollection 2023.
2
Drug-induced liver injury: a comprehensive review.药物性肝损伤:综述
Therap Adv Gastroenterol. 2023 Mar 21;16:17562848231163410. doi: 10.1177/17562848231163410. eCollection 2023.
3
Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
尿液代谢组学和微生物组学分析揭示了抗结核药物性肝损伤的作用机制,采用更新的 RUCAM 评估因果关系:一项前瞻性研究。
Front Immunol. 2022 Nov 22;13:1002126. doi: 10.3389/fimmu.2022.1002126. eCollection 2022.
4
Untargeted Metabolomics by Liquid Chromatography-Mass Spectrometry in Biomedical Research.基于液相色谱-质谱联用的非靶向代谢组学在生物医学研究中的应用。
Methods Mol Biol. 2023;2571:57-69. doi: 10.1007/978-1-0716-2699-3_6.
5
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment.代谢组学在药物性肝损伤(DILI)评估中的潜在作用。
Metabolites. 2022 Jun 19;12(6):564. doi: 10.3390/metabo12060564.
6
Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury.慢性药物性肝损伤组织学纤维化阶段的代谢组学分析
Front Pharmacol. 2022 May 20;13:896198. doi: 10.3389/fphar.2022.896198. eCollection 2022.
7
Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury.胆汁酸和 ω-6 多不饱和脂肪酸的改变与药物性肝损伤的进展和预后相关。
Front Immunol. 2022 Apr 12;13:772368. doi: 10.3389/fimmu.2022.772368. eCollection 2022.
8
Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.使用更新后的罗塞尔·优克福因果关系评估方法对新生儿和重症监护病房儿童药物性肝损伤进行因果关系评估。
Front Pharmacol. 2021 Dec 20;12:790108. doi: 10.3389/fphar.2021.790108. eCollection 2021.
9
Research Progress of Pharmacogenomics in Drug-Induced Liver Injury.药物基因组学在药物性肝损伤中的研究进展
Front Pharmacol. 2021 Sep 6;12:735260. doi: 10.3389/fphar.2021.735260. eCollection 2021.
10
Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.特异质性药物性肝损伤(DILI)的机制:尚未解决的基本问题。
Ann Transl Med. 2021 Apr;9(8):730. doi: 10.21037/atm-2020-ubih-05.